APO Research
Talk to an analyst

APO RESEARCH · REPORT

Josamycin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Josamycin Market Outlook and Growth Opportunities 2026

22 December 2025195 pages

Choose your research edition.

Industry ResearchJosamycin Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Josamycin Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Josamycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Josamycin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Josamycin Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Josamycin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Josamycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Josamycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Josamycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Josamycin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Josamycin market include Tosun Pharm, CSPC, SINE, Minsheng Pharma, BioChemPartner, Guilin Pharma, Bayer, Guanghua Pharma and SAJA Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Josamycin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Josamycin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Josamycin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Josamycin market size, projected growth trends, production technologies, key applications, and end-use industries.

Josamycin Segment by Company

Tosun Pharm

CSPC

SINE

Minsheng Pharma

BioChemPartner

Guilin Pharma

Bayer

Guanghua Pharma

SAJA Pharma

Ferrer International

Dragon Pharm

Astellas

Josamycin Segment by Type

99% Purity Type

98% Purity Type

95% Purity Type

Others

Josamycin Segment by Application

Josamycin Tablets

Propidinium Propionate Granule

Others

Josamycin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Josamycin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Josamycin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Josamycin significant trends, drivers, influence factors in global and regions.

6. To analyze Josamycin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Josamycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Josamycin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Josamycin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Josamycin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Josamycin industry.

Chapter 3: Detailed analysis of Josamycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Josamycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Josamycin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Josamycin Industry Trends Table 2. Josamycin Industry Drivers Table 3. Josamycin Industry Opportunities and Challenges Table 4. Josamycin Industry Restraints Table 5. Global Josamycin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Josamycin Revenue Share by Company (2021-2026) Table 7. Global Josamycin Sales Volume by Company (tons) & (2021-2026) Table 8. Global Josamycin Sales Volume Share by Company (2021-2026) Table 9. Global Josamycin Average Price (US$/ton) of Company (2021-2026) Table 10. Global Josamycin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Josamycin Key Company Manufacturing Base & Headquarters Table 12. Global Josamycin Company, Product Type & Application Table 13. Global Josamycin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Josamycin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 99% Purity Type Table 18. Significant Companies of 98% Purity Type Table 19. Significant Companies of 95% Purity Type Table 20. Significant Companies of Others Table 21. Global Josamycin Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 22. Global Josamycin Sales Volume by Type (2021-2026) & (tons) Table 23. Global Josamycin Sales Volume by Type (2027-2032) & (tons) Table 24. Global Josamycin Sales Volume Share by Type (2021-2026) Table 25. Global Josamycin Sales Volume Share by Type (2027-2032) Table 26. Global Josamycin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Josamycin Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Josamycin Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Josamycin Sales Value Share by Type (2021-2026) Table 30. Global Josamycin Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Josamycin Tablets Table 32. Significant Companies of Propidinium Propionate Granule Table 33. Significant Companies of Others Table 34. Global Josamycin Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 35. Global Josamycin Sales Volume by Application (2021-2026) & (tons) Table 36. Global Josamycin Sales Volume by Application (2027-2032) & (tons) Table 37. Global Josamycin Sales Volume Share by Application (2021-2026) Table 38. Global Josamycin Sales Volume Share by Application (2027-2032) Table 39. Global Josamycin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Josamycin Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Josamycin Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Josamycin Sales Value Share by Application (2021-2026) Table 43. Global Josamycin Sales Value Share by Application (2027-2032) Table 44. Global Josamycin Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 45. Global Josamycin Sales by Region (2021-2026) & (tons) Table 46. Global Josamycin Sales Market Share by Region (2021-2026) Table 47. Global Josamycin Sales by Region (2027-2032) & (tons) Table 48. Global Josamycin Sales Market Share by Region (2027-2032) Table 49. Global Josamycin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Josamycin Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Josamycin Sales Value Share by Region (2021-2026) Table 52. Global Josamycin Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Josamycin Sales Value Share by Region (2027-2032) Table 54. Global Josamycin Market Average Price (US$/ton) by Region (2021-2026) Table 55. Global Josamycin Market Average Price (US$/ton) by Region (2027-2032) Table 56. Global Josamycin Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 57. Global Josamycin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Josamycin Sales by Country (2021-2026) & (tons) Table 59. Global Josamycin Sales Market Share by Country (2021-2026) Table 60. Global Josamycin Sales by Country (2027-2032) & (tons) Table 61. Global Josamycin Sales Market Share by Country (2027-2032) Table 62. Global Josamycin Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Josamycin Sales Value Market Share by Country (2021-2026) Table 64. Global Josamycin Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Josamycin Sales Value Market Share by Country (2027-2032) Table 66. Tosun Pharm Company Information Table 67. Tosun Pharm Business Overview Table 68. Tosun Pharm Josamycin Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 69. Tosun Pharm Josamycin Product Portfolio Table 70. Tosun Pharm Recent Development Table 71. CSPC Company Information Table 72. CSPC Business Overview Table 73. CSPC Josamycin Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 74. CSPC Josamycin Product Portfolio Table 75. CSPC Recent Development Table 76. SINE Company Information Table 77. SINE Business Overview Table 78. SINE Josamycin Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 79. SINE Josamycin Product Portfolio Table 80. SINE Recent Development Table 81. Minsheng Pharma Company Information Table 82. Minsheng Pharma Business Overview Table 83. Minsheng Pharma Josamycin Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 84. Minsheng Pharma Josamycin Product Portfolio Table 85. Minsheng Pharma Recent Development Table 86. BioChemPartner Company Information Table 87. BioChemPartner Business Overview Table 88. BioChemPartner Josamycin Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 89. BioChemPartner Josamycin Product Portfolio Table 90. BioChemPartner Recent Development Table 91. Guilin Pharma Company Information Table 92. Guilin Pharma Business Overview Table 93. Guilin Pharma Josamycin Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 94. Guilin Pharma Josamycin Product Portfolio Table 95. Guilin Pharma Recent Development Table 96. Bayer Company Information Table 97. Bayer Business Overview Table 98. Bayer Josamycin Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 99. Bayer Josamycin Product Portfolio Table 100. Bayer Recent Development Table 101. Guanghua Pharma Company Information Table 102. Guanghua Pharma Business Overview Table 103. Guanghua Pharma Josamycin Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 104. Guanghua Pharma Josamycin Product Portfolio Table 105. Guanghua Pharma Recent Development Table 106. SAJA Pharma Company Information Table 107. SAJA Pharma Business Overview Table 108. SAJA Pharma Josamycin Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 109. SAJA Pharma Josamycin Product Portfolio Table 110. SAJA Pharma Recent Development Table 111. Ferrer International Company Information Table 112. Ferrer International Business Overview Table 113. Ferrer International Josamycin Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 114. Ferrer International Josamycin Product Portfolio Table 115. Ferrer International Recent Development Table 116. Dragon Pharm Company Information Table 117. Dragon Pharm Business Overview Table 118. Dragon Pharm Josamycin Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 119. Dragon Pharm Josamycin Product Portfolio Table 120. Dragon Pharm Recent Development Table 121. Astellas Company Information Table 122. Astellas Business Overview Table 123. Astellas Josamycin Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 124. Astellas Josamycin Product Portfolio Table 125. Astellas Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Josamycin Distributors List Table 129. Josamycin Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Josamycin Product Image Figure 2. Global Josamycin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Josamycin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Josamycin Sales (2021-2032) & (tons) Figure 5. Global Josamycin Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global Josamycin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 99% Purity Type Image Figure 10. 98% Purity Type Image Figure 11. 95% Purity Type Image Figure 12. Others Image Figure 13. Global Josamycin Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 14. Global Josamycin Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Josamycin Sales Volume Share by Type (2021-2032) Figure 16. Global Josamycin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Josamycin Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Josamycin Sales Value Share by Type (2021-2032) Figure 19. Josamycin Tablets Image Figure 20. Propidinium Propionate Granule Image Figure 21. Others Image Figure 22. Global Josamycin Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 23. Global Josamycin Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Josamycin Sales Volume Share by Application (2021-2032) Figure 25. Global Josamycin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Josamycin Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Josamycin Sales Value Share by Application (2021-2032) Figure 28. Global Josamycin Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 29. Global Josamycin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Josamycin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Josamycin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Josamycin Sales Value (2021-2032) & (US$ Million) Figure 33. North America Josamycin Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Josamycin Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Josamycin Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Josamycin Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Josamycin Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Josamycin Sales Value (2021-2032) & (US$ Million) Figure 39. South America Josamycin Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Josamycin Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Josamycin Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Josamycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Josamycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Josamycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Josamycin Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Josamycin Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 99% Purity Type
  • 98% Purity Type
  • 95% Purity Type
  • Others
Applications
  • Josamycin Tablets
  • Propidinium Propionate Granule
  • Others
Companies covered
  • Tosun Pharm
  • CSPC
  • SINE
  • Minsheng Pharma
  • BioChemPartner
  • Guilin Pharma
  • Bayer
  • Guanghua Pharma
  • SAJA Pharma
  • Ferrer International
  • Dragon Pharm
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Josamycin Sales Value (2021-2032)
  4. 1.2.2 Global Josamycin Sales Volume (2021-2032)
  5. 1.2.3 Global Josamycin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Josamycin Market Dynamics
  1. 2.1 Josamycin Industry Trends
  2. 2.2 Josamycin Industry Drivers
  3. 2.3 Josamycin Industry Opportunities and Challenges
  4. 2.4 Josamycin Industry Restraints
3 Josamycin Market by Company
  1. 3.1 Global Josamycin Company Revenue Ranking in 2025
  2. 3.2 Global Josamycin Revenue by Company (2021-2026)
  3. 3.3 Global Josamycin Sales Volume by Company (2021-2026)
  4. 3.4 Global Josamycin Average Price by Company (2021-2026)
  5. 3.5 Global Josamycin Company Ranking (2024-2026)
  6. 3.6 Global Josamycin Company Manufacturing Base and Headquarters
  7. 3.7 Global Josamycin Company Product Type and Application
  8. 3.8 Global Josamycin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Josamycin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Josamycin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Josamycin Market by Type
  1. 4.1 Josamycin Type Introduction
  2. 4.1.1 99% Purity Type
  3. 4.1.2 98% Purity Type
  4. 4.1.3 95% Purity Type
  5. 4.1.4 Others
  6. 4.2 Global Josamycin Sales Volume by Type
  7. 4.2.1 Global Josamycin Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Josamycin Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Josamycin Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Josamycin Sales Value by Type
  11. 4.3.1 Global Josamycin Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Josamycin Sales Value by Type (2021-2032)
  13. 4.3.3 Global Josamycin Sales Value Share by Type (2021-2032)
5 Josamycin Market by Application
  1. 5.1 Josamycin Application Introduction
  2. 5.1.1 Josamycin Tablets
  3. 5.1.2 Propidinium Propionate Granule
  4. 5.1.3 Others
  5. 5.2 Global Josamycin Sales Volume by Application
  6. 5.2.1 Global Josamycin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Josamycin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Josamycin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Josamycin Sales Value by Application
  10. 5.3.1 Global Josamycin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Josamycin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Josamycin Sales Value Share by Application (2021-2032)
6 Josamycin Regional Sales and Value Analysis
  1. 6.1 Global Josamycin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Josamycin Sales by Region (2021-2032)
  3. 6.2.1 Global Josamycin Sales by Region: 2021-2026
  4. 6.2.2 Global Josamycin Sales by Region (2027-2032)
  5. 6.3 Global Josamycin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Josamycin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Josamycin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Josamycin Sales Value by Region (2027-2032)
  9. 6.5 Global Josamycin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Josamycin Sales Value (2021-2032)
  12. 6.6.2 North America Josamycin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Josamycin Sales Value (2021-2032)
  15. 6.7.2 Europe Josamycin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Josamycin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Josamycin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Josamycin Sales Value (2021-2032)
  21. 6.9.2 South America Josamycin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Josamycin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Josamycin Sales Value Share by Country, 2025 VS 2032
7 Josamycin Country-level Sales and Value Analysis
  1. 7.1 Global Josamycin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Josamycin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Josamycin Sales by Country (2021-2032)
  4. 7.3.1 Global Josamycin Sales by Country (2021-2026)
  5. 7.3.2 Global Josamycin Sales by Country (2027-2032)
  6. 7.4 Global Josamycin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Josamycin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Josamycin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Josamycin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Josamycin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Josamycin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Josamycin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Josamycin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Josamycin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Josamycin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Josamycin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Josamycin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Josamycin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Josamycin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Josamycin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Josamycin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Josamycin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Josamycin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Josamycin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Josamycin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Josamycin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Josamycin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Josamycin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Josamycin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Josamycin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Josamycin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Josamycin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Josamycin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Josamycin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Josamycin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Josamycin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Josamycin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Josamycin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Josamycin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Josamycin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Josamycin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Josamycin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Josamycin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Josamycin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Josamycin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Josamycin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Josamycin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Josamycin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Josamycin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Josamycin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Josamycin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Josamycin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Josamycin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Josamycin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Josamycin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Josamycin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Josamycin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Josamycin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Josamycin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Josamycin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Josamycin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Josamycin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Josamycin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Josamycin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Josamycin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Josamycin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Josamycin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Josamycin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Josamycin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Josamycin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Josamycin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Josamycin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Josamycin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Josamycin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Josamycin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Josamycin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Josamycin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Josamycin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Josamycin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Josamycin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Josamycin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Josamycin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Josamycin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Josamycin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Josamycin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Josamycin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Josamycin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Josamycin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Josamycin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Josamycin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Josamycin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Josamycin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Tosun Pharm
  2. 8.1.1 Tosun Pharm Company Information
  3. 8.1.2 Tosun Pharm Business Overview
  4. 8.1.3 Tosun Pharm Josamycin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Tosun Pharm Josamycin Product Portfolio
  6. 8.1.5 Tosun Pharm Recent Developments
  7. 8.2 CSPC
  8. 8.2.1 CSPC Company Information
  9. 8.2.2 CSPC Business Overview
  10. 8.2.3 CSPC Josamycin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 CSPC Josamycin Product Portfolio
  12. 8.2.5 CSPC Recent Developments
  13. 8.3 SINE
  14. 8.3.1 SINE Company Information
  15. 8.3.2 SINE Business Overview
  16. 8.3.3 SINE Josamycin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 SINE Josamycin Product Portfolio
  18. 8.3.5 SINE Recent Developments
  19. 8.4 Minsheng Pharma
  20. 8.4.1 Minsheng Pharma Company Information
  21. 8.4.2 Minsheng Pharma Business Overview
  22. 8.4.3 Minsheng Pharma Josamycin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Minsheng Pharma Josamycin Product Portfolio
  24. 8.4.5 Minsheng Pharma Recent Developments
  25. 8.5 BioChemPartner
  26. 8.5.1 BioChemPartner Company Information
  27. 8.5.2 BioChemPartner Business Overview
  28. 8.5.3 BioChemPartner Josamycin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 BioChemPartner Josamycin Product Portfolio
  30. 8.5.5 BioChemPartner Recent Developments
  31. 8.6 Guilin Pharma
  32. 8.6.1 Guilin Pharma Company Information
  33. 8.6.2 Guilin Pharma Business Overview
  34. 8.6.3 Guilin Pharma Josamycin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Guilin Pharma Josamycin Product Portfolio
  36. 8.6.5 Guilin Pharma Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Josamycin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Josamycin Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 Guanghua Pharma
  44. 8.8.1 Guanghua Pharma Company Information
  45. 8.8.2 Guanghua Pharma Business Overview
  46. 8.8.3 Guanghua Pharma Josamycin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Guanghua Pharma Josamycin Product Portfolio
  48. 8.8.5 Guanghua Pharma Recent Developments
  49. 8.9 SAJA Pharma
  50. 8.9.1 SAJA Pharma Company Information
  51. 8.9.2 SAJA Pharma Business Overview
  52. 8.9.3 SAJA Pharma Josamycin Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 SAJA Pharma Josamycin Product Portfolio
  54. 8.9.5 SAJA Pharma Recent Developments
  55. 8.10 Ferrer International
  56. 8.10.1 Ferrer International Company Information
  57. 8.10.2 Ferrer International Business Overview
  58. 8.10.3 Ferrer International Josamycin Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Ferrer International Josamycin Product Portfolio
  60. 8.10.5 Ferrer International Recent Developments
  61. 8.11 Dragon Pharm
  62. 8.11.1 Dragon Pharm Company Information
  63. 8.11.2 Dragon Pharm Business Overview
  64. 8.11.3 Dragon Pharm Josamycin Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Dragon Pharm Josamycin Product Portfolio
  66. 8.11.5 Dragon Pharm Recent Developments
  67. 8.12 Astellas
  68. 8.12.1 Astellas Company Information
  69. 8.12.2 Astellas Business Overview
  70. 8.12.3 Astellas Josamycin Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Astellas Josamycin Product Portfolio
  72. 8.12.5 Astellas Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Josamycin Value Chain Analysis
  2. 9.1.1 Josamycin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Josamycin Sales Mode & Process
  6. 9.2 Josamycin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Josamycin Distributors
  9. 9.2.3 Josamycin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst